Global Canine Influenza Vaccine Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Canine influenza vaccine Market

Canine influenza vaccine market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.10% in the above-mentioned research forecast period. The increasing number of canine influenza in developed countries and new vaccine launches.

Increasing collaboration and partnership and technological advancement for vaccine delivery devices also boost up the market growth. Moreover, increasing research and development and rising healthcare expenditure act as opportunity for the market growth. But, product recall, strict regulations and lack of skilled professionals may hamper the global canine influenza vaccine market.

Canine influenza is one of the highly contagious disease caused by viral infection that affects both cats and dogs population. Canine influenza is a Type A influenza virus which can be identified on the basis of two specific proteins present in lipid outer layer of capsid that are hemagglutinin and neuraminidase. The two basic strain of influenza virus recognized till now includes H3N8 and H3N2. Influenza viruses have the ability to quickly change itself and to give rise to new strain types which can affect different types of species. Canine influenza is transmitted via droplets or aerosols comprises of secretions of barking, sneezing and coughing. Moreover canine influenza can also be transmitted through contact with infected dogs. Canine influenza vaccine is available for both kinds of influenza strains.

Canine influenza virus has the ability to change its serotypes and hence inhibits the host immune response which poses challenges in front of physicians and patients to fight against such diseases. This challenge paves the way for vaccine manufacturer to come up with new and novel vaccine launch and hence expected to provide market with the lucrative growth.

This canine influenza vaccine market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Canine Influenza Vaccine Market Scope and Market Size

Canine influenza vaccine market is segmented on the basis of treatment type, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of vaccine type, the canine influenza vaccine type market is segmented into powder and dry.
• On the basis of end-users, the canine influenza vaccine market is segmented into home, pet clinic, other.
• On the basis of distribution channel, the canine influenza vaccine market has also been segmented into retail pharmacy, online pharmacy, others. 

Canine influenza vaccine Market Country Level Analysis

Canine influenza vaccine market is analysed and market size information is provided by country, treatment type, end-users and distribution channel as referenced above.

The countries covered in the canine influenza vaccine market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rising prevalence of canine influenza in U.S. and increasing product launch. Europe accounts the second largest market share due to wide distribution network and increasing collaboration and partnership for development of technologically advanced vaccine administration devices.  Asia-Pacific is expected to account for the largest market share over coming years for the canine influenza vaccine market due to increasing demand of effective therapies and the growing investment for establishment of new manufacturing facilities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Canine influenza vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Canine influenza vaccine Market Share Analysis

Canine influenza vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to canine influenza vaccine market.

The major players covered in the canine influenza vaccine market are Zoetis Services LLC, Intervet Inc., CSL Limited, Covetrus, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

• In December 2017, Zoetis launched Vanguard CIV H3N2/H3N8 Vaccine indicated for prevention of canine influenza virus. The vaccine launched is a bivalent vaccine which protects dogs against both the types of canine influenza strain. This product launch boosted the company’s product portfolio and allowed it to attain a lucrative growth in canine influenza vaccine market.

SKU-60137